Asian Myeloproliferative Neoplasm (MPN) Registry

Sponsor
The University of Hong Kong
Study ID
NCT05882773
Status
Recruiting
Apply to this trial

Conditions

  • Essential Thrombocythemia
  • Myeloproliferative Neoplasm
  • Polycythemia Vera
  • Post-essential Thrombocythemia Myelofibrosis
  • Post-polycythemia Vera Myelofibrosis
  • Primary Myelofibrosis
  • Primary Myelofibrosis, Fibrotic Stage
  • Primary Myelofibrosis, Prefibrotic Stage

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

This is a multinational, multicenter, prospective and retrospective, observational, cohort study of patients with myeloproliferative neoplasm.

Key Dates

First listed
May 31, 2023
Start date
May 31, 2023
Status verified
May 2023
Primary completion
May 31, 2026
Completion
Dec 31, 2026

Study Design

Enrollment
1,000 participants (estimated)

Primary Outcome Measure

Time to progression to secondary myelofibrosis (for PV and ET) [ Time Frame: 10 years ]

Central Contacts

Related Studies